Author:
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 901 | 605 | 58 |
| Full Text Views | 11 | 0 | 0 |
| PDF Downloads | 5 | 0 | 0 |
A 13-Year Follow-up of Antimony-Treated Schistosoma Mansoni-Infected Patients
Per Hedman
Per Hedman
Roslagstull Hospital, Karolinska Institute, Stockholm, Sweden
Search for other papers by Per Hedman in
Current site
Google Scholar
PubMed
Search for other papers by Per Hedman in
Current site
Google Scholar
PubMed
Elias Bengtsson
Elias Bengtsson
Roslagstull Hospital, Karolinska Institute, Stockholm, Sweden
Search for other papers by Elias Bengtsson in
Current site
Google Scholar
PubMed
Search for other papers by Elias Bengtsson in
Current site
Google Scholar
PubMed
Thirty consecutive patients who were treated for Schistosoma mansoni infection with antimony sodium dimercaptosuccinate (Astiban) during the 1960s, and who had not visited an endemic area since the treatment, were reexamined 11 to 17 (average 13) years after the last presumed exposure. Seven of them (23%) still had active infections, six being chronic infections of which only one had been treated in an acute stage. None of the patients with chronic S. mansoni infection had signs of changes in liver, gut, or other organs, and all were able to work at full capacity. Living eggs were found in rectal biopsy specimens from all cases, but in only two cases in stool specimens. Serological reactions were positive in three cases and also in two of the egg-negative cases. Skin tests gave immediate positive reactions in 6 of 7 egg-positive and in 11 of 23 egg-negative patients.
Author Notes
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 901 | 605 | 58 |
| Full Text Views | 11 | 0 | 0 |
| PDF Downloads | 5 | 0 | 0 |